During Thursday’s Current trade, Shares of Swift Transportation Co (NYSE:SWFT), lost -1.12% to $23.62.
Swift Transportation Company (SWFT), a leader in transportation solutions and the nation’s largest truckload provider, has issued its Letter to Stockholders for the second quarter ended June 30, 2015. This letter is presently accessible on Swift’s investor relations website: http://investor.swifttrans.com/ and will be filed with the SEC on a form 8-K.
Swift Transportation Company operates as a multi-faceted transportation services company in North America. The company operates through four segments: Truckload, Dedicated, Central Refrigerated, and Intermodal. The Truckload segment provides services through one-way movements over irregular routes utilizing company’s and owner-operator tractors with dry van, flatbed, and specialized trailing equipment. The Dedicated segment offers tailored solutions under long-term contracts utilizing refrigerated, dry van, flatbed, and other specialized trailing equipment.
Shares of Hudson City Bancorp, Inc. (NASDAQ:HCBK), declined -0.14% to $10.35, during its current trading session.
Hudson City Bancorp, Inc. ( HCBK) the holding company for Hudson City Savings Bank (the “Bank”), recently stated net income of $35.7 million for the quarter ended June 30, 2015 as contrast to net income of $39.2 million for the quarter ended June 30, 2014. Diluted earnings per share amounted to $0.07 for the second quarter of 2015 as contrast to diluted earnings per share of $0.08 for the second quarter of 2014. For the six months ended June 30, 2015, the Company stated net income of $41.5 million as contrast to net income of $81.7 million for the six months ended June 30, 2014. Diluted earnings per share amounted to $0.08 for the six months ended June 30, 2015 as contrast to diluted earnings per share of $0.16 for the six months ended June 30, 2014.
The Company also stated recently that the Board of Directors declared a quarterly cash dividend of $0.04 per share payable on September 2, 2015 to shareholders of record on August 13, 2015.
Hudson City Bancorp, Inc. operates as the holding company of Hudson City Savings Bank that provides various banking products and services in the United States. Its deposit products comprise passbook and statement savings accounts, interest-bearing transaction accounts, checking accounts, money market accounts, and time deposits, in addition to IRA accounts and qualified retirement plans.
Raptor Pharmaceutical Corp. (NASDAQ:RPTP), during its Thursday’s current trading session decreased -1.05% to $14.13.
Raptor Pharmaceutical Corp. (RPTP) declared the appointment of Ashley Gould, J.D. as its Senior Vice President, General Counsel and Corporate Governance. In addition, Ted Daley, Chief Business Officer, will be leaving the company at the end of September to pursue other interests.
Most recently Ms. Gould served as Senior Vice President, Governmental Affairs and Chief Legal and Compliance Officer for Hyperion Therapeutics. Before that, she held a number of positions of increasing responsibility at 23andMe, culminating in her appointment as Vice President, Corporate Development and Chief Legal Officer. Formerly she was Vice President, Legal Affairs at CoTherix, where she worked on the company’s acquisition by Actelion, and an associate at the law firms of O’Melveny & Myers and Wilson Sonsini Goodrich & Rosati. Ms. Gould received a B.S. in Political Economy of Natural Resources from University of California, Berkeley and a J.D. from the University of San Francisco School of Law.
Raptor Pharmaceutical Corp., a biopharmaceutical company, focuses on developing and commercializing life-altering therapeutics that treat debilitating and often fatal diseases. The company offers PROCYSBI, a delayed-release capsule, which is used for the administration of nephropathic cystinosis in adults, in addition to in six years and older children in the United States, in the 28 member states of the European Union, Norway, Liechtenstein, and Iceland. Its clinical development programs comprise RP103 that is used as a treatment for Huntington’s disease; RP103 as a treatment for non-alcoholic fatty liver disease in children; and RP103 as a treatment for mitochondrial disorders, counting Leigh syndrome.
Finally, EQT Corporation (NYSE:EQT), decreased -0.36%, to $74.17.
EQT Corporation (EQT) declared completion of the flow-back operation on its Scotts Run 591340 dry Utica well located in Greene County, Pennsylvania. Last week, EQT Corporation declared the well’s 24-hour deliverability test of 72.9 MMcf per day, with an average flowing wellhead pressure of 8,641 psi. Following the 24-hour deliverability test, the well produced an average of 27.0 MMcf per day for a period of seven days under restricted choke, with an average flowing pressure of 9,563 psi.
The well is presently shut-in for installation of permanent production facilities that the Company anticipates to complete next week, after which a choke restricted rate of 25-30 MMcf per day is predictable. The BTU content of the well is 1.018 MMBtu/Mcf with 98.5% methane.
The Company will drill a second dry Utica well on an existing Marcellus pad in Greene County in August. Located about five miles northeast of the Scotts Run pad, this well is predictable to have a 13,400 foot vertical depth and a 4,000 – 4,500 foot lateral. In order to reduce overall well costs, the Company intends to apply lessons learned from drilling its first Greene County Utica well. As formerly declared, EQT will spud a dry Utica well in Wetzel County, West Virginia in September. This well is predictable to have a 12,700 foot vertical depth and a 3,000 – 3,500 foot lateral.
EQT Corporation, together with its auxiliaries, operates as a natural gas company in the United States. It operates in two segments, EQT Production and EQT Midstream. The EQT Production segment explores for, in addition to develops and produces natural gas, natural gas liquids (NGLs), and crude oil primarily in the Appalachian Basin.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
